Glucagon-like peptide-1 receptor agonists, also known as GLP-1 agonists, GLP-1 receptor agonists, GLP-1 RAs, incretin mimetics, or GLP-1 analogs, are a class of medications used to treat people with type 2 diabetes mellitus (T2DM) and obesity
(Legrand et al., 2016), it also accumulated in Achillea millefolium L
The FDA's decision to restrict teen approval reflects this evidence gap rather than proof of harmhighlighting the need for caution and personalized assessment
Daily topical minoxidil 5% on non-needling days
GLP-1 receptor agonists are effective for treating obesity and diabetes, but the high cost and high rates of gastrointestinal adverse effects can lead to treatment cessation and subsequent weight regain, the researchers explained
The challenge with healthcare benefits is that the conversation cannot stop at the cost of the treatment